Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$14.16 - $24.3 $739,421 - $1.27 Million
-52,219 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$21.79 - $28.29 $1.14 Million - $1.48 Million
52,219 New
52,219 $1.25 Million
Q4 2017

Feb 14, 2018

SELL
$9.3 - $19.14 $1.09 Million - $2.24 Million
-117,131 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$9.15 - $11.97 $1.07 Million - $1.4 Million
117,131
117,131 $1.23 Billion

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.31B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.